These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8651019)

  • 41. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow.
    Jagels MA; Hugli TE
    J Immunol; 1992 Feb; 148(4):1119-28. PubMed ID: 1310708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury.
    Pfister RR; Haddox JL; Sommers CI
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1744-50. PubMed ID: 9699566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation.
    Seegers BA; Andriessen MP; van Hooijdonk CA; de Bakker ES; van Vlijmen-Willems IM; Parker GL; van Erp PE; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2000; 13(2):75-85. PubMed ID: 10754455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
    Dos Santos C; Davidson D
    Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukotriene B4 costimulates 5-lipoxygenase activity in neutrophils via increased 5-lipoxygenase translocation.
    Serio KJ; Baker JR; Ring WL; Riddick CA; Bigby TD
    Am J Physiol; 1997 Apr; 272(4 Pt 1):C1329-34. PubMed ID: 9142859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells.
    Chung JW; Kim GY; Mun YC; Ahn JY; Seong CM; Kim JH
    Exp Mol Med; 2005 Feb; 37(1):45-50. PubMed ID: 15761251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of selenium deficiency on caprine polymorphonuclear leukocyte production of leukotriene B4 and its neutrophil chemotactic activity.
    Aziz E; Klesius PH
    Am J Vet Res; 1986 Feb; 47(2):426-8. PubMed ID: 3006557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The leukotriene B
    Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
    Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells.
    Du L; Yin H; Morrow JD; Strobel HW; Keeney DS
    Arch Biochem Biophys; 2009 Apr; 484(1):80-6. PubMed ID: 19467632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative human skin using an optimized thermolysin-trypsin protocol.
    Glade CP; Seegers BA; Meulen EF; van Hooijdonk CA; van Erp PE; van de Kerkhof PC
    Arch Dermatol Res; 1996 Apr; 288(4):203-10. PubMed ID: 8967793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
    de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
    van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
    Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An ultrastructural study of the response of normal skin to epicutaneous application of leukotriene B4.
    van de Kerkhof PC; Peereboom-Stegeman JH; Boeijen J
    J Dermatol; 1991 May; 18(5):271-6. PubMed ID: 1658100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.
    Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC
    Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.